Related by context. All words. (Click for frequent words.) 61 #,#,#,# [011] 59 #,#,#,# [004] 58 #,#,# [016] 56 #OHD 56 interrater reliability 55 ALT elevation 54 % Confidence Interval 54 hemoglobin Hb 54 #,#,# [010] 54 J Clin Oncol 54 abstr 54 adjunctive placebo 54 ‰ ¥ 54 #-#,# [007] 53 :5 53 suppl. 53 Supplementary Appendix 53 fig. S2 53 Comparators 53 MADRS score 53 APACHE II 53 â ‰ ¥ 53 #.#-#.# [011] 53 #,#,#,#,#,# [003] 53 logistic regression analyzes 53 :7 53 -2 -3 53 confidence intervals CIs 53 Pearson correlation coefficient 52 State Exam MMSE 52 p ≤ 52 affective psychosis 52 μg d 52 subscore 52 #,#-# [003] 52 r2 = 52 tertiles 52 LV ejection fraction 52 Brief Psychiatric 52 Ann Intern Med 52 odds ratios ORs 52 regression coefficients 52 Index CDAI 52 S1 S# [001] 52 mL/min/#.# m 2 52 overt hypothyroidism 52 plasma cortisol 52 serum cortisol 52 Br J Dermatol 52 lumbar spine BMD 52 -#.# log# 52 subthreshold 52 neutropaenia 51 mmol l 51 -#.# ± [002] 51 Eur Urol 51 femoral neck BMD 51 μg liter 51 Confidence Intervals 51 #:#-# [002] 51 μmol L 51 Double Blind Randomized 51 intact parathyroid hormone 51 μg L 51 χ 51 Supplemental Figure 51 J Urol 51 Historical Volatility 51 PANSS total 51 postmenopausal osteoporotic women 51 % CI #.#-#.# [003] 51 univariate 51 doi #.# 51 variance ANOVA 51 = #.#-#.# 51 Nat Genet 51 subscores 51 ng dL 51 p = NS 51 AUC0 51 gadolinium enhancing 51 logistic regression model 51 ug kg 51 Supplementary Table 51 μg kg 51 Suppl. 51 Fig. 3b 51 J Pediatr 51 biopsy Gleason 51 Montgomery Åsberg Depression 51 multivariable analysis 51 cells uL 51 ìg 51 interrater 51 Crohn Disease Activity 51 Am Fam Physician 51 Stent Restenosis 51 Ann Emerg Med 51 ROC curve 51 aortic insufficiency 51 #,#,#,#,# [005] 51 alanine aminotransferase 51 Δ 51 VNTR 51 Pain Intensity 51 Castration Resistant Prostate Cancer 51 State Examination MMSE 51 NTx 50 histologic subtype 50 regression coefficient 50 HGPIN 50 HADS 50 #:#-# [031] 50 Neurol 50 J Child Adolesc 50 URBAN ACTION 50 nmol liter 50 Oral Fingolimod 50 tPSA 50 #/#/#/# [004] 50 μg dl 50 hypophosphatemia 50 #S #S [003] 50 FASEB J. 50 #,#,#,# [001] 50 Histologic 50 uM 50 Arch Neurol 50 CHADS 50 Tf 50 Free Full Text 50 PHPT 50 pretest probability 50 PaO 2 50 ischemic lesions 50 baseline FEV 50 IELT 50 Am J Cardiol 50 somatostatin analog 50 Betaferon R 50 #Gy 50 ANCOVA 50 Main Outcome Measures 50 Hrly 50 mIU ml 50 DAS# CRP 50 :4 50 mg TID 50 postvaccination 50 collagenous colitis 50 Alanine 50 Mth 50 UPDRS motor 50 NIH CPSI 50 serum ferritin 50 covariate 50 Peginterferon Alfa 2a 50 CIN3 50 Eur J Cancer 49 CDAI score 49 :3 49 #,#-# [012] 49 Pharmacodynamics 49 % CI #.#-#.# [008] 49 Main Outcome Measure 49 covariance ANCOVA 49 Kaplan Meier curves 49 reflux esophagitis 49 #,#-# [008] 49 ECOG PS 49 EndoTAG ® 49 Clinical Relevance 49 Kaplan Meier estimates 49 ACE Inhibitor 49 #ppm U 49 interquartile range IQR 49 Standard Deviation 49 Cancer Res 49 macroalbuminuria 49 bivalirudin monotherapy 49 Visual Analogue Scale VAS 49 hip BMD 49 Arch Intern Med 49 interferon α 49 Mantel Haenszel 49 Severity Index PASI 49 interquartile range 49 Figure 1C 49 #-#,# mg 49 Ejection Fraction 49 Kaplan Meier 49 mg BID dose 49 Kaplan Meier curve 49 J Virol 49 J Am Soc 49 Score DAS 49 mH 49 HbA 1c levels 49 SVR# 49 heterozygotes 49 To Width Au 49 serum testosterone 49 microgram kg 49 sonographically 49 diastolic velocity 49 Figure 1a 49 Urol 49 -#/# [003] 49 pmol L 49 #.#mg/dL 49 #:#-# [033] 49 laboratory abnormalities 49 CI -#.# 49 dose Iluvien 49 Int J Epidemiol 49 serum urate levels 49 Hourly Earnings 49 leukocyte count 49 Cardiotoxicity 49 Antiviral Therapy 49 mU liter 49 Arch Dermatol 49 transvaginal sonography 49 Mol Psychiatry 49 Fibonacci Retracement 49 ISAR REACT 49 T3 T4 49 Fig. 1b 49 serum magnesium 49 Platelet Aggregation 49 umol L 49 Follicular Lymphoma 49 J Natl Cancer Inst 49 echogenic bowel 49 ALT elevations 49 Acute Physiology 49 MMSE score 49 serum HBV DNA 49 aspartate aminotransferase 49 HDRS 49 NSABP B 49 antibody titer 49 relapsed MM 49 troponin T 49 WOMAC pain 49 #:#-# [029] 49 #S #S [002] 49 umbilical artery 49 pathologic diagnosis 49 pairwise comparisons 48 #,#,#,# [003] 48 % CI #.#-#.# [004] 48 paresthesias 48 CIN2 + 48 Accumulation Distribution 48 tipranavir r 48 #.#,#.# [002] 48 nmol l 48 Rating Scale BPRS 48 NMIBC 48 microg 48 Kidney Int 48 hemodynamically significant 48 mCi m 2 48 T1a 48 silica SiO2 48 pld 48 Br J Cancer 48 Histopathologic 48 Hemoglobin A1c 48 prevalences 48 DAS# remission 48 univariate analyzes 48 #,#,# [020] 48 #.#-#.# [005] 48 TNSS 48 PEG IFN 48 :9 48 BEL Kawasaki 48 CHADS2 48 :6 48 Genotypes 48 Prehypertension 48 posttest 48 #N [003] 48 HBeAg negative 48 stomatitis pharyngitis 48 URTI 48 KOOS 48 QIDS SR 48 intraclass correlation coefficients 48 pT2 48 confidence interval #.#-#.# 48 parasitaemia 48 mg/m2/day 48 interobserver 48 ROC curves 48 multivariable adjusted 48 neuropathy sensory 48 % CuEQ 48 Percentile 48 Subtypes 48 #/#/#/# [003] 48 crossclamp 48 rFSH 48 Thrombolysis 48 -India Kanishka bombing 48 multiple logistic regression 48 SCr 48 -Cúper 48 lipid lowering agents 48 Suppl 48 C#BL/#J mice 48 lymphopenia 48 J Foot Ankle 48 femoral shaft fracture 48 SOUTHS ACACIA 48 pg ml 48 Brain Metastases 48 Ishak fibrosis score 48 K#N 48 correlation coefficients 48 Severity Index 48 mRS 48 ,8 48 Â ± 48 periprocedural 48 ALT flares 48 antenatal corticosteroids 48 multivariate Cox 48 alanine aminotransferase ALT 48 +#.# bps [002] 48 SBP DBP 48 lateral radiograph 48 Rheumatol 48 #μg [001] 48 QRS duration 48 #,#,#,#,#,# [002] 48 FiO 48 prucalopride 48 #p# [003] 48 Eq. 48 J Clin Psychiatry 48 Ann Oncol 48 categorical variables 48 Eur Respir J 48 postintervention 48 Clinical Outcome 48 #a #a [002] 48 Merit FOM 48 hyperintensity 48 Stratified 48 CR nPR 48 Oncol 48 hydroxyvitamin D levels 48 adiponectin concentrations 48 #.#mmol L [002] 48 oxycodone CR 48 Diseases Ninth 48 CLL SLL 48 See WARNINGS 48 Interleukin IL 48 preoperative PSA 48 La#O# 48 AOR = 48 -8 -9 48 p = #.# [003] 48 Kaplan Meier analysis 48 lopinavir r arm 48 rs# [001] 48 CI -#.# -#.# 48 YMRS 48 transaminase elevations 48 mg qd 48 Oral Presentation 48 Injury Severity Score 48 FDG uptake 48 Prostaglandin 48 Rare Earth Oxides TREO 48 Non Responders 48 #.#K [005] 48 NNT = 48 IBDQ 48 triiodothyronine 48 intraclass correlation coefficient 48 CORE OM 47 piotr.skolimowski @ thomson.com 47 bowel syndrome IBS 47 aortic regurgitation 47 Controlled Trial 47 HREO TREO 47 histological subtype 47 Unweighted 47 Papillary 47 IFN α 47 Wistar rats 47 ± SEM 47 Randomised 47 Nephrol Dial Transplant 47 D dimer 47 DLTs 47 aspartate aminotransferase AST 47 serum creatinine levels 47 IPSS 47 CIN2 47 Reproduced Record RR 47 IIIb 47 HOMA IR 47 micrograms mL 47 Cronbach alpha 47 Uterine 47 Kruskal Wallis test 47 AUCs 47 seropositivity 47 AuEq g t 47 Systolic 47 BMI z 47 MDRD 47 baseline Hb 47 generalized edema 47 apnea hypopnea 47 Gastrointestinal Stromal Tumors 47 5-FU/LV 47 bivariate 47 9l 47 Poisson regression 47 mean ± SEM 47 suppl 47 Supplementary Figs 47 Partial Response 47 Å -1 47 x ULN 47 Mineral Resource Summary 47 serum TSH 47 MACCE 47 Lung Cancer Trial 47 baseline LDH 47 mdn aut 47 UPDRS 47 BILAG 47 creatinine clearance 47 § #E 47 Serum concentrations 47 syndromal 47 male Wistar rats 47 Rating Scale MADRS 47 mcg mL 47 Sports Exerc 47 Equiv 47 PLND 47 EDSS scores 47 posttreatment 47 Hypertens 47 Subgroup analysis 47 IQR 47 Abstract Number 47 I# I# [002] 47 dI dV 47 homozygotes 47 abdominal adiposity 47 Beta Blockers 47 hematological parameters 47 ASCUS 47 LS BMD 47 metaplasia 47 autocorrelation 47 % CI #.#-#.# [007] 47 pg mL 47 -tau gene 47 TRUS 47 Hazard Ratio HR 47 unfractionated heparin UFH 47 Kellgren Lawrence 47 Psychopharmacol Bull 47 #:# [008] 47 somatoform disorders 47 ß blockers 47 Clin Endocrinol 47 serum estradiol 47 nondiabetic patients 47 DOI #.#/S#-# 47 #,#,#,#,# [008] 47 #,#,# [013] 47 J Nutr 47 urolithiasis 47 Cr#O# 47 interobserver reliability 47 distal femur 47 antitrypsin 47 tertile 47 HBeAg negative patients 47 HDL Cholesterol 47 #ug [002] 47 Wilcoxon rank sum 47 λ 47 Nat Clin Pract 47 -1 -2 47 ml min 47 Dent Res 47 carotid stenosis 47 echocardiographic parameters 47 neutropenia dehydration dyspnea 47 HbA 1c 47 ω 47 lognormal 47 Secondary Endpoints 47 per deciliter mg 47 Prognostic Value 47 BENCHMRK 47 ADAS cog 47 gadolinium enhanced 47 serum prostate 47 -Genereaux 47 neutropenia febrile neutropenia 47 mIU L 47 piotr.skolimowski @ thomsonreuters.com 47 FEV ^ sub 47 Red Hat alert RHSA 47 Arch Facial Plast 47 telopeptide 47 allele frequencies 47 suppl #S 47 osteopenic 47 mE 47 CFNAI 47 #.#/journal.pmed.# 47 Pesos Ps 47 cerebral infarctions 47 Pain Rating Scale 47 coronary stenosis 47 betamethasone 47 serum sodium 47 X ULN 47 adenoma recurrence 47 WOLSTON PARK 47 isoprostane 47 #,#,# [024] 47 Adjuvant Treatment 47 Statistically Significant 47 #mmHg [001] 47 glycated hemoglobin 47 0D 47 IIEF 47 :0 47 Eur J Neurol 47 ANOVA 46 NJSA 2C :5 46 EURIDIS 46 Acta Psychiatrica Scandinavica 46 multivariate analyzes 46 Aggrenox R 46 undetectable HBV DNA 46 Obes Res 46 Critically Ill Patients 46 subscale scores 46 immunostaining 46 B# [004] 46 Kidney Function 46 Hb A1C 46 specific antigen PSA 46 nmol 46 centistokes 46 Hormone Refractory Prostate Cancer 46 Analogues 46 ipsilateral stroke 46 T1c 46 Unfractionated Heparin 46 LPV r 46 κ 46 onset diabetes mellitus 46 EQ 5D 46 Interval m 46 Clin Oncol 46 -5 -6 46 Immunohistochemical staining 46 cough dyspnea 46 BB# [002] 46 Nd#O# 46 endometrial thickness 46 serum IGF 46 -#.# mmol L 46 RAEB 46 Pred Forte 46 cGy 46 NIHSS 46 extensive metabolizers 46 CHD mortality 46 Psychiatr Serv 46 Cholinesterase Inhibitors 46 Operative mortality 46 CVD mortality 46 Figure 2C 46 Sagittal 46 carotid IMT 46 nonvertebral 46 SpO 2 46 TEXT OMITTED FROM SOURCE 46 Histopathological 46 #mg/m# [001] 46 albumin excretion 46 histopathologic 46 β blockers 46 aortic root replacement 46 PSA nadir 46 2n = 46 Apolipoprotein 46 creatinine ratio 46 Skin sterol 46 mg/# hours 46 rs# [004] 46 LFQ 46 Qtrs 46 surgically resected 46 earning Beyer Speed 46 albumin excretion rate 46 lymphadenectomy 46 Southwell 1m 6f hcp 46 serum ALT 46 True thicknesses 46 #:#-# [037] 46 Am J Epidemiol 46 SUVmax 46 REYATAZ r arm 46 independent prognostic marker 46 #m@#.#g t Au [001] 46 hours postdose 46 intraventricular hemorrhage 46 cm proximal 46 #.# subd [004] 46 fructosamine 46 J Rheumatol 46 § § #-#-# [001] 46 Lysis 46 nonvertebral fractures 46 D Dimer 46 mammographic density 46 Pricing Supplement 46 Int J 46 Preoperatively 46 aminotransferase levels 46 somatization disorder 46 colorectal adenoma 46 4mg/kg 46 NHANES III 46 WAIS III 46 multiple linear regression 46 AST ALT 46 metronidazole gel 46 biochemical recurrence 46 nmol L. 46 serum aminotransferase levels 46 Scale EDSS score 46 Fig. 2A 46 symptomatic VTE 46 HER2 expression 46 #.#/# [005] 46 3AB 46 Differential Diagnosis 46 LV dysfunction 46 Joshua Coppins NZL Aprilia 46 TIMP 46 Epithelial Cell 46 Consensus +#.# 46 EDSS score 46 MT GRAVATT 46 adjuvant trastuzumab 46 +2 +2 46 echogenicity 46 transaminases 46 intraobserver 46 Cardiac Troponin 46 IPAH 46 angiographically 46 HBeAg seroconversion 46 -Kosslyn 46 Ref. 46 Score IPSS 46 HRCT 46 NIHSS score 46 Psychiatry Res 46 invasive carcinomas 46 variogram 46 Rs.# w 46 metres@#.# g t Au [002] 46 multivariate regression analysis 46 urine albumin 46 J Orthop 46 elevated transaminases 46 QTcF 46 periprocedural MI 46 -Greg Stoda Palm Beach 46 urinary albumin excretion 46 logistic regression 46 Histological 46 4yo + 46 ng dl 46 FDA defined valvulopathy 46 μg dL 46 HbA 1C 46 platelet reactivity 46 #.cxd# [002] 46 pmol 46 thyroglobulin 46 mEq L 46 iii iv 46 definite stent thrombosis 46 Mg ha 46 NJSA #A 46 Nucl Med 46 #mo [002] 46 m@#.# g t Au [002] 46 grade squamous intraepithelial 46 #.#/# [020] 46 Non Inferiority 46 Postoperative complications 46 mU L 46 Fasting blood glucose 46 % #.pdf 46 vs.# 45 Curr Opin 45 Doppler sonography 45 de novo AML 45 45 pimecrolimus cream 45 T1 weighted images 45 NHANES #-# 45 aged ≥ 45 CVZ 45 serum calcium 45 lymphocytosis 45 hydronephrosis 45 Million ozs 45 centile 45 g t Au Ounces 45 mmol L. 45 pT3 45 Dilatation 45 hemoglobin concentrations 45 mcL 45 g cm 45 CC genotype 45 ¾ l 45 peak VO2 45 Somerville Hse 45 plasminogen activator inhibitor 45 GOLF CLUBS 45 intraventricular 45 ms -1 45 Polymorphism 45 postoperative mortality 45 Androgen Deprivation 45 Inj 45 m@#.# g t Au [003] 45 interobserver agreement 45 diabetes mellitus DM 45 pulmonary arterial 45 ^ F FDG 45 postoperative radiographs 45 HIV seronegative 45 HAM D# 45 Fumbles Lost 45 gadolinium enhancing lesions 45 rapid virological response 45 hypercalciuria 45 proximal femoral 45 Ann Rheum Dis 45 On KASE fixing 45 #,#,#,#,# [002] 45 Specificity 45 ileal 45 ¼ l 45 PSQI 45 chi squared 45 reactive hyperemia 45 mmHg diastolic 45 fluorodeoxyglucose positron emission tomography 45 = .# 45 -NTRA Thoroughbred Poll 45 STUD PLATE 45 metres@#.# g t Au [003] 45 document.write unescape % 45 HMGA1 45 osteochondroma 45 Mammographic 45 Claudication 45 #mg q8h 45 Alzheimer Disease Assessment 45 #h #min 45 -mother Arndrea 45 Randomized Study 45 XIENCE V PROMUS Stent 45 β = 45 Bonferroni correction 45 Soy Isoflavones 45 ° preoperatively 45 Replikin Count 45 cTnI 45 Coronary Arteries 45 clinically meaningful improvement 45 death reinfarction 45 Pearson correlation coefficients 45 #.#-# b [002] 45 ± SD 45 multivariate logistic regression 45 Nat Rev Neurosci 45 severe NCI Grades 45 doxorubicin cyclophosphamide 45 Incr 45 Rui Goncalves POR KTM 45 pegylated liposomal doxorubicin PLD 45 MMSE 45 C.2 45 HBeAg 45 semiquantitative 45 + sizeof 45 rating/# 45 allele frequency 45 anemia hemoglobin 45 rev. 45 DVFA SG 45 mg kg bw 45 Figure 1A 45 Kaplan Meier method 45 Clin Cancer 45 FRI OCT 45 PANSS 45 -stephen lawson@idg.com 45 Orthostatic Hypotension 45 Left Ventricular Ejection Fraction 45 tHcy concentrations 45 Toxicol 45 L1 L2 45 :2 45 ha -1 45 PEY 45 cardiac perfusion 45 Partial Nephrectomy 45 #S #S [001] 45 cytokeratin 45 τ 45 Crit Care 45 PMID # [002] 45 Biol Psychiatry 45 Randomized Controlled Trials 45 Vertebral 45 Month Avg 45 acute cholecystitis 45 advanced adenoma 45 HLA A2 45 Randomized Phase II 45 serum lipid levels 45 Figs. 45 tHcy 45 p = .# [002] 45 Semester Exam 45 Appears Safe 45 Fecal Incontinence 45 USC § § #e 45 urinary N telopeptide 45 spud #-#-# drlg [002] 45 SAT OCT 45 BPH Symptom Score 45 Linearity 45 mg kg -1 45 Coronary Artery Calcium 45 SMITHFIELD FOODS INC. AND 45 interleukin IL 45 mm ^ sup 45 multivariable Cox 45 Induction Chemotherapy 45 transaminase levels 45 pyrexia mucositis sepsis febrile 45 achieved ACR# 45 -vs. Sonjay Dutt 45 IV# [001] 45 #beta hydroxysteroid dehydrogenase 45 UTM UTM 45 logistic regression analysis 45 apolipoprotein B 45 Mbp 45 biochemical relapse 45 σ 45 USC #d 45 baseline HbA1c 45 diastolic pressures 45 serum triglyceride 45 distal radial fractures 45 Left Ventricular 45 baseline CD4 45 ml kg 45 Width m 45 Psychosom Med 45 nondiabetics 45 Kd2 45 seroprevalence 45 morphologic characteristics 45 WOMAC 45 elevated creatinine 45 e# e# [002] 45 scores TNSS 45 antiretroviral naïve 45 min -1 45 Paediatr 45 International Prognostic Scoring 45 BPS IC 45 central corneal thickness 45 #:#-# [014] 45 ν 45 serum CRP 45 Patients Receiving 45 efavirenz EFV 45 binary restenosis 45 sh hd 45 -Amaka Anajemba 45 patrick.graham @ thomson.com 45 #m Hfd 45 HBET# 45 Cu Pb 45 cytoreductive nephrectomy 45 non hematologic toxicities 45 immunoreactivity 45 Morphological 45 leucopenia 45 Addict Behav 45 Univariate 45 Id. § 45 GISSI 45 -#-# [004] 45 #b #S 45 phosphate P#O# 45 grade cervical intraepithelial 45 +#-# [019] 45 proximal tibia 45 Predict Response 45 #-#/#L 1L 45 True Width 45 ErbB2 positive 45 deoxy 45 Proc Am 45 0E 45 Thyroxine 45 neoplasias 45 Cropredy Res 45 nausea dehydration dyspnea 45 TEAEs 45 Lowers Blood Pressure 45 IV NSCLC 45 Fig. 2c 45 ° -# ° [002] 45 #ppb Au [002] 45 metabolic parameters 45 Am J Clin 45 neurologic impairment 45 Interrater reliability 45 weighted avg 45 5 hydroxytryptamine 45 Initiated Phase 45 Occupancy Rate 45 univariate analysis 45 karyotype 45 transferrin saturation 45 Duration Gap 45 ^ sup -1 45 SBM frequency 45 generalized estimating 45 recurrent VTE 45 logistic regression models 45 SELENA SLEDAI score 45 thyrotropin levels 45 NYHA functional class 45 #,# #,# #,# [004] 45 Oswestry Disability Index 45 seronegative 45 pawel.sobczak @ thomson.com 45 oxyhemoglobin 45 NO spud #-#-# 45 μg ml 45 #E [002] 45 Cr Fe 45 landmark ATHENA trial 45 ventricular myocardium 45 To Length Au 45 sht nk 45 NPH insulin 45 mg m² 45 s# s# 45 PANSS scores 45 spine BMD 44 intraabdominal 44 RLAI 44 logMAR 44 intracerebral hemorrhages 44 Stent Placement 44 systolic BP 44 nonparametric 44 Phospholipase 44 tigecycline 44 ALGESTER 44 fig. S3